Introduction
Fluorescently labelled peptides form a new class of analytical tools to visualize intracellular processes and molecular interactions at the level of single cells. The peptide-based reporters combine the sensitivity of fluorescence detection with the information specificity of amino acid sequences. Fluorescently labelled peptide-hormones have been used to detect the binding of hormones to receptors at the cellular surface (1) and their subsequent internalization and routing to acidic intracellular compartments (2) . A number of fluorescent substrates have been developed to detect the activity of proteases (3) . Fluorescently labelled heptapeptides mimicking the carboxy-terminal sequence of N-ras, were reversibly acylated in cultured mammalian fibroblasts (4) . A fluorescent substrate of protein kinase A was used to detect the activation of this enzyme by L-glutamate in cultured hippocampal neurons (5) .
Here we report on the expansion of this technology with membrane-permeant Peptide-based targeting of fluorophores to organelles in living cells fluorescent peptides that accumulate specifically in cellular organelles. Targeting of these peptides to the organelles uses the protein sorting machinery that directs newly synthesized proteins to their distinct destination. Proteins predestined for the peroxisomes and nucleus are synthesized on ribosomes in the cytosol. They accumulate in their target organelles by interaction with receptors that facilitate active import. Conversely, proteins that are synthesized on ERbound ribosomes are co-translationally translocated into the lumen of this organelle. Dependent on the presence of a retention signal (e.g. KDEL) they are retained in the ER or are targeted to other compartments of the endocytic pathway such as the Golgi apparatus (see for overview ref. 6 ). Tyrosine-containing motifs play an important role in intracellular protein trafficking as well. For instance, the sequence SXYQRL is a retention signal for proteins residing in the TGN (7, 8) .
In the present paper, we have investigated whether sequences that are recognized by organelle-specific protein-sorting machineries, could be used to target the fluorophore BODIPY 581/591 to the peroxisomes, nucleus, ER and TGN in intact cells. By a similar approach, we have recently determined the pH in peroxisomes using a peptide carrying a peroxisomal targeting sequence (PTS) and a pH sensitive fluorophore (9).
Materials and Methods

Chemicals
All peptides (> 95% pure) were obtained from Ansynth Service BV Roosendaal, The Netherlands. All fluorophores used were obtained from Molecular Probes (Eugene, OR, USA. All other chemicals used were obtained from Sigma (St. Louis, MO, USA) or Merck (Darmstadt, Germany).
Fluorescent labelling of the peptides An iodacetamide derivative of C2-BODIPY 581/591 was synthesized and coupled to the sulfuratom of a single cysteine-residue in the peptides. The fluorophore was coupled to iodoacetamide by adding 50 µl of 200 mM iodoacetamide in bicine buffer (50 mM, pH 8.5) to 50 µl of a 15 mM C2-BODIPY 581/591 SE solution in THF. The reaction was carried out under subdued light for one hour. After the reaction, the excess iodoacetamide was removed by acidic extraction. For this purpose 200 µl chloroform, 100 µl water and 5 µl acetic acid were added and the mixture was vortexed and the water phase was removed. The extraction was repeated four times. The product in the chloroform phase was dried under a stream of nitrogen. Next, a five times molar excess of BODIPY-Iodacetamide in tetrahydrofuran was added to 5 µg of peptide dissolved in 100 µl 0.1 M TRIS (pH 7.4). The reducing agent Tris-(2-carboxyethyl)phosphine (0.1 mM) was added to prevent the formation of disulfide bonds. The mixture was stirred for 24 h at room temperature in the dark. Subsequently the reaction mixture was extracted as describe above. With this extraction the unreacted dye partitioned in the chloroform phase and the labelled peptide in the water phase. The extraction was repeated three times. The purity of the fluorescent products was about 95% as verified by thin layer chromatography on silica 60 plates using the eluent: chloroform : methanol : acetic acid : water (25 : 15 : 3 : 2 v/v). Alternatively to the labelling on the cysteine, the TGN peptide was also labelled at the N-terminus by incubating the peptide with a ten-fold excess of C2-BODIPY 581/591 succinimidyl ester in bicine buffer (20 mM Bicine, pH 8.4) for 1 h at room temperature.
Labelling of the cells Prior to use, rat-1 fibroblasts were grown at least 24 h on glass coverslips (25-mm diameter, Fisher) to 80% confluence in DMEM containing 10% fetal bovine serum, 20 units/ml penicillin, and 20 µg/ml streptomycin under 5% CO 2 . Cells were placed in the temperature-controlled cover slip holder of the microscope set at 37°C. The cells were rinsed with enriched phosphatebuffered saline (PBS ++ : 137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl 2 , 0.9 mM CaCl 2 , 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , supplemented with 5 mM glucose, pH 37 ο C 7.4) and then incubated with PBS ++ containing the fluorescent peptides (± 5 µg/ml) for up to 30 min. After uptake of the peptides, the cells were washed with fresh PBS ++ . Similar uptake experiments were carried out at 4°C. To examine the functionality of the NLS-peptide, the plasma membrane of the rat-1 fibroblasts was punctured with glass beads (10) . To this end, the fluorescent NLS-peptide was added to the culture medium at a concentration of ± 15 µg/ml. Then glass beads (Ø 106 µ, Sigma) were sprinkled onto the cells and removed after 5 min by washing. After the treatment, the cells remained adherent and well-spread. They were used immediately for microscopic examination.
Colocalisation with organelle-specific markers. The subcellular localization of the TGN-peptide was determined using NBD-ceramide as a marker for the trans Golgi network. After loading with the TGN-peptide, the cells were exposed for 15 min to PBS ++ containing 0.1 µM NBD-ceramide. Subsequently, the cells were washed with fresh PBS ++ . As an ER-marker, concanavalin A was used. The distribution of the KDEL-peptide in the cells was imaged. Subsequently, while mounted under the microscope, the cells were fixed and permeabilized using 4% paraformaldehyde in PBS containing 0.1% triton X100 for 15 min at room temperature. Excess fixative was scavenged with 100 mM glycine for 2 times 10 min. The cells were blocked with 5% bovine serum in PBS with 0.1% serum albumin for 20 min at room temperature, washed and incubated with tetramethylrhodamine-labelled concanavalin A. After 20 min the excess of concanavalin A was removed by washing three times with PBS and images were taken.
Confocal Laser Scanning microscopy Images were taken with a Leica TCSNT confocal laser-scanning system on an inverted microscope DMIRBE (Leica Microsystems, GmbH, Heidelberg, Germany) with an argonkrypton laser as excitation source. The green or red fluorescence of labelled peptides was acquired using the 488 and 568 nm laserlines for excitation and the emission bandpass filters 530/30 and 590/30 for detection, respectively. Adobe Photoshop (Mountain View, CA) was used to assemble and label the images. GASDYQRLGC 0 * The underlined residues indicate the import or retention sequence; the cysteine residue in italic is coupled to the fluorophore.
Results
Design of organelle-specific fluorescent peptides. The boron dipyrromethene difluorid fluorophore C2-BODIPY 581/591 exhibits a bright red fluorescence with wavelength of maximal excitation and emission of 581/591 nm, respectively. It is uncharged and has a preference for the cell membrane (its calculated octanol : water partition coefficient (Log-P) corresponds to ± 3). Administration of the free fluorophore to the growth medium of rat-1 fibroblasts leads to a rapid incorporation into the cells. Typically the fluorescence was visible after 1 min or less. The distribution of the probe is diffuse and no distinct selectivity for any subcellular site was observed (data not shown).
To evaluate whether C2-BODIPY 581/591 can be targeted to various cellular organelles, we have coupled the probe to four different carrier-peptides with known import or retention sequences (table 1) . A single cysteine residue was present in all peptides used so as to ensure a site of coupling for the thiol-reactive derivative of the fluorophore. To circumvent interference of the fluorophore with the site of recognition, one to three (mostly hydroophobic) amino acid residues were positioned between the cysteine residue and the targeting motif. For targeting of C2-BODIPY 581/591 to peroxisomes, we have used the peptide CKGGAKL (table 1) . The tripeptide AKL is representative for the peroxisomal targeting signal-1 (PTS1) and is located at the carboxy-terminus of most peroxisomal matrix proteins (11) . For targeting of C2-BODIPY 581/591 to the nucleus, we used the classical localization signal (NLS) composed of four to five consecutive basic amino acids (reviewed in ref.
12). Here we tested the NLS peptide VVVKKKRKVVC derived from the nuclear leader sequence of the simian virus SV40 large tumour antigen (13) . The acetylated form of this peptide has four net positive charges (table 1) . The carboxyl-terminal KDEL peptide is an important retrieval signal of lumenal ER proteins that have escaped to the Golgi apparatus and other post-ER compartments (14) . The KDEL receptor is concentrated in the intermediate compartment, as well as in the Golgi stack (15) . After binding to this receptor, the proteins are transported to the ER by way of retrograde vesicle-flow. In order to target C2-BODIPY 581/591 to the ER, we designed the peptide CFFKDEL containing this ER retention motif (table 1) Tyrosine-containing motifs play an important role in the internalization of integral membrane proteins at the cell surface and their subsequent targeting to the TGN. They are present in cytosolic domains of the integral membrane proteins and have been shown to interact with the medium chain subunits of adaptor complexes such as AP-2 that are associated with clathrin coated vesicles (16) . In order to target C2-BODIPY 581/591 to the TGN, the fluorophore was coupled to a peptide GASDYQRLGC containing the motif SDYQRL of the integral membrane protein TGN38 (7, 8) . This protein cycles between the TGN and the plasma membrane but is predominantly found in the TGN. As an alternative to labelling at the cysteine residue, the TGN peptide was also labelled at the amino-terminus using the succinimidyl ester derivative of C2-BODIPY 581/591 .
Targeting of fluorescent peptides to cellular organelles. The uptake of the PTS1, KDEL and TGN-peptides by rat-1 fibroblasts from the medium is a rapid process. The first indication that the peptides are targeted to the organelles is already visible after 1 min (figure 1). After 16 min of incubation, targeting of all three peptides is complete. Distinct targeting remains clearly visible after the cells were washed to remove the excess probe from the medium and incubated for another 5 min ( figure 1, last frame) .
The PTS1-peptide is concentrated in small grain-like organelles after 11 min of loading ( figure 1A) . As shown in a previous study with rat-1 fibroblasts (17) this punctated staining completely co-localized with antibodies against the peroxisomal acyl-coA oxidase indicating that the PTS1-peptide is indeed accumulated in peroxisomes. A similar punctated distribution of the PTS1-peptide has been observed in human fibroblasts (9) . Initially, the KDEL-peptide is distributed throughout the cell but after 11 min of loading it concentrates within a large perinuclear compartment (figure 1B). This compartment was identified as ER by labelling the cells after fixation and permeabilization with the ER-marker concanavalin A ( figure 2 A, B) . Identification of the site of localization has also been performed with an antibody against the KDEL receptor. The data confirmed that the bulk of this receptor is localized in the Golgi apparatus (7, 8) . We presume that there is a continuous transport of the KDEL-peptide-receptor complex from the Golgi to the ER where the peptide is then released. This would imply that the capacity of the KDEL-receptors is sufficient to result in a net import of the KDEL-peptide in the ER.
As shown in Figure 1 C, the TGN-peptide accumulates in structures close to the nucleus. These structures are already visible after 6 min of loading to become very distinct within 16 min. From the extensive colocalisation with 7-nitrobenz-2-oxa-1,3-diazole-ceramide (NBD-ceramide), a well-known marker of TGN, we infer that the bulk of the TGN-peptide accumulates within the TGN ( figure 2 C, D) . In addition, a fraction of this peptide is present in structures close to the TGN in which the NBD-ceramide is absent. These may represent 
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endocytic vesicles that cycle from the plasma membrane to the TGN as was observed for the membrane protein TGN38 (8) . We have also tested the TGN-peptide with the fluorescent label attached to the amino-terminus. This peptide was also rapidly taken up by the cells and targeted to the TGN (data not shown). The NLS-peptide carrying four positive charges was not internalized, yet concentrated at the cellular surface ( figure 3A) . When the plasma membrane of these cells was punctured by the impact of glass beads, the NLS-peptide was found to accumulate almost instantaneously (figure 3 B) . The charged amino acid residues required to target the peptide to the nucleus most likely prevent the peptide from crossing the plasma membrane (12) .
Effect of temperature. The way the fluorescent PTS1-, KDEL-and TGN-peptides enter the cells is still a matter of investigation. To assess whether endocytosis is involved, the uptake of these peptides was determined at 4°C. Internalization by way of coated vesicles and endosomes is blocked at this temperature (18) . After 15 min of loading, the cells were washed with cold medium and images were taken. Under these conditions, the PTS1-, KDEL-and TGN-peptides are effectively internalized ( figure 4 A, B and C) . This implies that endocytosis is not required for the uptake. On the other hand, it appears that at this low temperature all three peptides are localized in structures adjacent to the nucleus and did not yet reach their target organelles. Targeting was attained by subsequently increasing the temperature to 37° C resulting in the accumulation of the peptides in peroxisomes, the ER and the TGN, respectively ( Figure 4D , E and F).
Discussion
Here we demonstrate that C2-BODIPY 581/591 added to intact rat-1 fibroblasts, can be targeted to four different organelles (i.e. peroxisomes, endoplasmic reticulum, the Golgi system and nuclei) provided the probe is coupled to peptides carrying specific import or retention sequences. In agreement with its distinct hydrophobicity, the unconjugated form is rapidly taken up by intact cells and distributes diffusely among the subcellular organelles. Similarly, the probe conjugated to the PTS1-, TGN-and KDEL peptides is effectively taken up by the cells indicating that the peptide moieties do not prevent the conjugates from crossing the plasma membrane. As shown in other studies (19) the uptake of small peptides (4-to 11-aminoacid residues) from the medium can be extensive and is mainly determined by net charge and by other physicochemical properties like hydrophobicity. In fact, several groups have shown that the efficacy of peptide-uptake can be enhanced by their acylation (20, 21) . In line with this, the C2-BODIPY 581/591 -labelled PTS1-, TGN-and KDEL peptides are presumably sufficiently hydrophobic so as to be able to pass the membrane. These peptides have net charges varying between +2 and -1 ( Table 1) . On the other hand, the C2-BODIPY 581/591 -labelled NLS-peptide carrying a net charge of +4 is membrane-impermeable. In this case, it appears that the hydrophobicity of the fluorescent moiety is not sufficient to overcome the excess positive charge of the conjugate. Routinely, the uptake of the peptides was carried out at 37°C. An effective uptake of the PTS1-, TGN-and KDEL peptides was also observed at 4°C. This strongly suggests that endocytosis is not involved in the cellular uptake of the peptides. Our observations are in agreement with other studies demonstrating that peptides are effectively internalized at low temperatures by passive diffusion (22, 23) .
Accumulation of the PTS1-peptide into peroxisomes is an ATP-dependent process involving the protein-import machinery specific for the PTS1 targeting signal (9, 11) . A complicating factor may be the rapid extrusion of the PTS1-peptide by the multidrug-resistant (MDR) proteins. So it was observed that in the case of HepG2 hepatoma cells accumulation into peroxisomes was effective provided the MDR-reversing agent verapamil was present (17) . In the case of the KDEL-peptide we assume that after passage through the plasma membrane, this peptide interacts with the KDEL-receptor which is predominantly located in the Golgi stack and in the intermediate compartment. This receptor can then be reached either by endocytosis or by passive diffusion. From these post-ER compartments, the peptide will be delivered to the ER by retrograde transport. Accumulation of the KDEL-peptide in the ER implies that its import surpasses export. After the TGN-peptide has crossed the plasma membrane its import into the TGN requires that it first interacts with adaptor proteins on the cytoplasmic side of the plasma membrane or endosomes (16) . In case of the endosomes, the interaction sites of the adaptor proteins are most likely accessible to the peptide from the cytosol. The TGN-peptide internalized at 4°C, will accumulate in the TGN at 37˚C. This suggests that the uptake and transport to the TGN are two independent events. It is to be noted that the peptides taken up at 4°C appear to be associated with structures particularly abundant around the nucleus (Figure 4) . However, this association appears to be reversible as an increase of the temperature to 37°C resulted in each peptide accumulating in its organelle proper. The identity of these structures remains to be elucidated.
The rapid translocation of fluorescent organelle-specific peptides across the plasma membrane offers the opportunity to image organelle-specific functions in living cells with time-and spatial resolution. So it was observed that upon addition of Brefeldin A to cells loaded with the TGN-peptide the TGN extended as tubules throughout the cytoplasm after 30 min of treatment. After 60 min the TGN-peptide accumulated into large vesicles that are distributed throughout the whole cell (unpublished observations). Similarly, exposure of the cells to the ionophore monensin for 30 min completely disrupted the TGN morphology resulting in the accumulation of the TGN peptide in large vesicles. These observations agree with previous studies using antibodies against TGN38 (24, 24) . In addition, the peptides can be used as diagnostic tools to evaluate the functional integrity of protein import or retention machineries in mutant cells and in cells of patients. Finally, the exact sequence requirements for import or retention could rapidly be determined with libraries of fluorescent peptides.
